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Abstract. Tororo, a district in Uganda with historically high malaria transmission intensity, has recently scaled up
control interventions, including universal long-lasting insecticidal net distribution in 2013 and 2017, and sustained indoor
residual spraying (IRS) of insecticide sinceDecember 2014.We describe the burden ofmalaria in Tororo 5 years following
the initiation of IRS. We followed a cohort of 531 participants from 80 randomly selected households in Nagongera
subcounty, Tororo district, from October 2017 to October 2019. Mosquitoes were collected every 2 weeks using CDC
light traps in all rooms where participants slept, symptomatic malaria was identified by passive surveillance, and mi-
croscopic and submicroscopic parasitemia were measured every 4 weeks using active surveillance. Over the 2 years of
follow-up, 15,780 female anophelinemosquitoswere collected, themajority (98.0%) ofwhichwereAnopheles arabiensis.
The daily human biting rate was 2.07, and the annual entomological inoculation rate was 0.43 infective bites/person/year.
Only 38 episodes of malaria were diagnosed (incidence 0.04 episodes/person/year), and there were no cases of severe
malaria or malarial deaths. The prevalence of microscopic parasitemia was 1.9%, and the combined prevalence of
microscopic and submicroscopic parasitemia was 10.4%, each highest in children aged 5–15 years (3.3% and 14.0%,
respectively). After 5 years of intensive vector control measures in Tororo, the burden of malaria was reduced to very low
transmission levels. However, a significant proportion of the population remained parasitemic, primarily school-aged
children with submicroscopic parasitemia, providing a potential reservoir for malaria transmission.
INTRODUCTION
The scale-up of proven malaria control interventions,
including indoor residual spraying (IRS) of insecticide, long-
lasting insecticidal nets (LLINs), and effective case manage-
ment with artemisinin-based combination therapies (ACTs),
has been associated with marked reductions in the global
burden ofmalaria. However, progress has leveled off in recent
years; in 2018 alone, there were an estimated 228 million
cases of malaria, of which 93%were from Africa, where more
than 99% of cases are due to Plasmodium falciparum.1 Most
worrying is that the malaria cases are on the rise across some
high-burden countries in Africa.1 Given these worrisome
trends, in 2018, theWHOandRoll BackMalaria Partnership to
End Malaria launched “high burden to high impact,” a new
approach that calls for using themost effective tools in amore
targeted way to prevent disease and save lives in countries
hardest hit.1
Uganda is emblematic of high-burden African countries,
ranking third in the total number ofmalaria cases in 2018.1 The
country has scaled upmalaria control throughout the country,
including the adoption of artemether–lumefantrine (AL) as
first-line treatment formalaria in 2004 anddistribution of LLINs
through mass universal coverage campaigns in 2013–2014
and 2016–2017. Indoor residual spraying was re-initiated in
2006, after a gap of 40 years, and is currently being imple-
mented in 14 of 135 districts. Although the scale-up of control
interventions in Uganda has been well documented, data on
changes in the burden and epidemiology of malaria are
limited. The most comprehensive data come from repeated
national Malaria Indicator Surveys (MIS) conducted in 2009,
2014–2015, and 2018–2019, which have documented a
decline in the prevalence of microscopic parasitemia in
children younger than 5 years from 42%2 to 19%3 to 9%
(2018 MIS, National Malaria Control Program, Uganda
Ministry of Health, unpublished data), respectively. How-
ever, these declines have not been uniform around the
country, and they have been greatest in regions where IRS
has been implemented.
Since 2011, our grouphasbeen conducting comprehensive
malaria surveillance in cohorts from Tororo district, Uganda,
an area with historically high transmission intensity that has
seen a dramatic decline in the burden ofmalaria since IRSwas
first implemented in December 2014. Here, we describe lon-
gitudinal measures of malaria transmission, infection, and
disease with a focus on the fourth and fifth years after IRSwas
implemented.
MATERIALS AND METHODS
Study setting and population level control interventions.
Cohort studies and entomological surveillance were con-
ducted in Nagongera subcounty, Tororo district, a pre-
dominantly rural area in eastern Uganda. Before 2013, malaria
control in Tororo was limited to the distribution of LLINs
through antenatal care services, promotion of intermittent
preventive treatment during pregnancy, and malaria case
management with AL. In November 2013, universal distribu-
tion of free LLINs was conducted as part of a national
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campaign, and a similar campaign was repeated inMay 2017.
Indoor residual spraying with carbamate bendiocarb was first
initiated in December 2014–January 2015, with additional
rounds administered in June 2015–July 2015 and November
2015–December 2015. In June 2016–July 2016, IRS was ad-
ministered with the organophosphate pirimiphos-methyl
(Actellic), with repeated rounds in June 2017–July 2017,
June 2018–July 2018, and March 2019–April 2019.
Theprimary focus of this report is clinical and entomological
surveillance conducted from October 2017 through October
2019 (referred to as “PRISM2” study), but to provide context,
we also include previously described summary data from
clinical and entomological surveillance conducted from Oc-
tober 2011 through September 2017 in the same study area
(referred to as “PRISM1” study).4–7 In PRISM1, all children
aged 0.5–10 years were enrolled from 100 houses randomly
selected fromNagongera subcounty. Study participants were
followed up for all of their healthcare needs in a dedicated
study clinic open 7 days per week. Routine visits were con-
ducted every 1–3months and included the collection of blood
for the assessment of parasitemia by microscopy and loop-
mediated isothermal amplification (LAMP). The cohort was
dynamic such that all newly eligible children fromparticipating
households were enrolled, and participants who reached 11
years of age were excluded from further follow-up. Mosquito
collections were done monthly in all cohort households using
CDC light traps. Entomological assessments included quan-
tifying the number of femaleAnopheles, species identification,
and the detection of sporozoites using ELISA.
Primary study population. In October 2017, households
that participated in the PRISM1 cohort study and randomly
selected new households within Nagongera subcounty were
screened and enrolled in the PRISM2 study if they met the
following criteria: 1) at least two household members younger
than 5 years (or younger than 10 years if enrolled in the prior
cohort study), 2) no more than seven permanent residents (or
nine permanent residents if enrolled in the prior cohort study),
3) no plans for the household to move from Nagongera sub-
county in the next 2 years, and 4) willing to participate in
screening for clinical and entomological surveillance. All per-
manent residents (regardless of age) from enrolled house-
holds were screened and enrolled in the cohort study if they
met the following criteria: 1) the selected household was
considered their primary residence, 2) agreement to come to
the study clinic for any febrile illness, 3) agreement to avoid
antimalarial medications outside the study, and 4) provision of
written informed consent. The cohort was dynamic such that
over the course of the study, any permanent residents who
joined the household were screened for enrollment. Partici-
pants were followed up through October 2019 (∼2 years) un-
less they were prematurely withdrawn if they met any of the
following criteria: 1) permanent movement out of Nagongera
subcounty, 2) unable to be located for > 120 days, 3) with-
drawal of informed consent, or 4) unable to comply with the
study schedule and procedures.
Enrollment and follow-up of cohort study participants.
At enrollment, a baseline evaluation which included a detailed
medical history, focused physical examination, and blood
collectedby venipuncture for hemoglobinmeasurement, thick
blood smear, and storage for future molecular studies was
conducted. A household survey was conducted to collect
information on characteristics of the household and LLIN
ownership. Following the household survey, all household
members were given a LLIN. Cohort study participants were
encouraged to come to a dedicated study clinic open 7 days
per week for all their medical care. Routine visits were con-
ducted every 4 weeks and included a standardized evaluation
and collection of blood by finger prick/heel stick (if < 6months
of age) or venipuncture (if aged 6 months and older) for thick
blood smear, hemoglobinmeasurement (every 12weeks), and
storage for future molecular studies. Study participants found
to have a fever (tympanic temperature > 38.0C) or a history of
fever in theprevious24hours at the timeof anyclinic visit hada
thick blood smear read immediately. If the thick blood smear
was positive by light microscopy, then the patient was di-
agnosed with malaria and managed according to national
guidelines.8 Study subjects who missed their scheduled rou-
tine visits were visited at home and requested to come to the
study clinic as soon as possible.
Entomological surveillance. Mosquito collections were
conducted every 2 weeks in all cohort study households. In
each room where cohort study participants slept, a miniature
CDC light trap (Model 512; John W. Hock Company, Gain-
esville, FL) was positioned 1m above the floor. Traps were set
at 7 PM and collected at 7 AM the following morning. Female
Anopheles were identified taxonomically to species level
based on morphological criteria according to established
taxonomic keys.9 Identification of members of the Anopheles
gambiae complex was performed by PCR10 for up to 30
mosquitoes randomly selected every 2 weeks. Sporozoites
were assessed in all female Anopheles mosquitoes stored
with desiccant using a standardized ELISA technique.11
Cohort study laboratory evaluations. Thick blood smears
were stained with 2% Giemsa for 30 minutes and evaluated for
the presence of asexual and sexual (gametocytes) parasites.
Parasite densities were calculated by counting the number of
asexual parasites per 200 leukocytes (or per 500, if the count
was less than 10 parasites per 200 leukocytes), assuming a
leukocyte count of 8,000/μL. A thick blood smear was con-
sidered negative if examination of 100 high-power fields
revealed no asexual parasites. For quality control, all slides
were read by a second microscopist, and a third reviewer
settled anydiscrepant readings.QuantitativePCR (qPCR)was
performed at the time of enrollment and at each routine visit
(every 4 weeks). DNA was extracted using Qiagen spin col-
umns, and extraction products were tested for the presence
and quantity of P. falciparum DNA via a highly sensitive qPCR
assay targeting the multi-copy conserved var gene acidic
terminal sequence, with a lower limit of detection of 1 parasite/
mL.12 All samples that were positive for asexual parasites by
microscopy but negative for P. falciparum by qPCR were
tested for the presence of non-falciparum species using
nested PCR.13 Hemoglobin measurements were performed
every 12 weeks using a portable spectrophotometer (Hemo-
Cue, Angelholm, Sweden).
Data analysis. All data were collected using standardized
case record forms and double-entered using Microsoft Ac-
cess (Microsoft Corporation, Redmond, WA). Analyses were
performed using Stata, version 14 (Stata Corporation, College
Station, TX). Baseline descriptive statistics included propor-
tions for categorical variables andmean (SD) ormedian (range)
values for continuous variables. Measures of transmission
were based on entomological surveillance data. It was not
possible to directlymeasure the daily humanbiting rate (HBR);
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therefore, this metric was estimated using the total number of
female Anophelesmosquitoes captured/number of CDC light
trap collections. Of note, prior work from our group in Uganda
has shown that estimated HBRs using the gold standard
method of human landing catches was strongly correlated
with those made using CDC light traps.14 The sporozoite rate
was calculated as the number of mosquitoes testing positive
for sporozoites/the number of mosquitoes tested. The annual
entomological inoculation rate (EIR) was estimated using the
product of the daily HBR and the sporozoite rate × 365 days/
year. Estimates of monthly rainfall were obtained from the
NASA Tropical Rainfall Measuring Mission Project.15 Clinical
metrics included measures of disease and infection stratified
by age-groups. The incidence ofmalariawas calculated as the
number of episodes of malaria confirmed by microscopy/
person years of observation. The prevalence of microscopic
parasitemia or gametocytemia was calculated as the number
of routine blood smears positive for asexual parasites or
sexual parasites, respectively/total number of routine blood
smears done. The prevalence of microscopic or sub-
microscopic parasitemia was calculated as the number of
routine samples positive by microscopy or qPCR/total num-
ber of routine assessments. The prevalence of anemia was
defined as the proportion of routine samples with hemoglobin
values below specific cutoffs based on prior MIS that have
been conducted in Uganda.
Data accessibility. Data from both cohort studies are
available through a novel open-access clinical epidemiology
database resource, ClinEpiDB.16 Data for the study con-
ducted from October 2011 through September 2017 (referred
to as “PRISM1”) can be found at https://clinepidb.org/ce/app/
record/dataset/DS_0ad509829e. Data for the study con-
ducted from October 2017 through October 2019 (referred to
as “PRISM2”) can be found at https://clinepidb.org/ce/app/
record/dataset/DS_51b40fe2e2.
Ethics statement. Ethical approval was obtained from the
Makerere University School of Medicine Research and Ethics
Committee, the Uganda National Council of Science and
Technology, the London School of Hygiene & Tropical Medi-
cine Ethics Committee, and the University of California, San
Francisco Committee on Human Research.
RESULTS
Summary findings from the PRISM1 cohort study. From
October 2011 through November 2014, before the imple-
mentation of IRS, there were two annual peaks in rainfall fol-
lowed by two annual peaks in vector density characteristic of
much of Uganda (Figure 1A). Pre-IRS, the daily HBRwas 34.3,
the annual EIR 238, and, among all female Anopheles cap-
tured, 67% were An. gambiae s.s., 22% An. arabiensis, 10%
An. funestus, and < 1% other Anopheles species. In the first
year following IRS with carbamate bendiocarb, the daily HBR
had reduced to 3.9 and the annual EIR to 12.4. Over the sec-
ond and third years of IRSwhen the formulation was switched
to the organophosphate pirimiphos-methyl (Actellic), the daily
HBR had reduced further to 1.8 and the annual EIR to 0.9.
Despite continuation of the two annual peaks in rainfall, in the
second and third years of IRS, there were only single annual
peaks in vector density, between May and June, and more
than 90% of all female Anopheles captured were An.
arabiensis.
Longitudinal trends in measures of infection and disease
among children aged 0.5–10 years are presented in Figure 1B.
Before the implementation of IRS, the incidence of malaria
was 2.96 episodes/person/year, the prevalence of micro-
scopic parasitemia 31.8%, and the combined prevalence of
microscopic and submicroscopic parasitemia 67.5%. In the
first year following IRS, the incidence of malaria reduced to
0.97 episodes/person/year, the prevalence of microscopic
parasitemia to 22.3%, and the combined prevalence of mi-
croscopic and submicroscopic parasitemia to 40.2%. Over
the second and third years of IRS, the incidence of malaria
reduced further to 0.50 episodes/person/year, the prevalence
of microscopic parasitemia to 8.7%, and the combined
prevalence of microscopic and submicroscopic parasitemia
to 15.8%.
Characteristics of the PRISM2 households and cohort
study participants. In October 2017, 413 households were
screened and 80 were enrolled, including 33 households from
the prior cohort and 47 new households (Figure 2). Of 80 en-
rolled households, 58 (72.5%) used traditional materials for
construction (thatch roof, mud walls, and open eaves), 78
(97.5%) had at least one LLIN, and 56 (70.0%) had at least one
LLIN per two persons (Table 1). All household members were
given an LLIN after enrollment. During the initial screening
period (October 2017), 466 participants were enrolled, and an
additional 65 were enrolled as they joined the households
during the 2-year follow-up period.
A total of 278 participants (52.4%) were female, and the
median age at enrollment was 8.7 years (IQR 3.7–26.5), with
approximately equal distribution between those aged < 5
years, 5–15 years, and > 15 years (Table 1). The proportion of
participants with microscopic parasitemia at enrollment was
5.7%, 8.3%, and 1.2% for those aged < 5 years, 5–15 years,
and > 15 years, respectively. The combined proportion of
participants with microscopic and submicroscopic para-
sitemia at enrollment was 9.0%, 23.3%, and 19.3% for those
aged < 5 years, 5–15 years, and > 15 years, respectively. At
enrollment, 21 participants (4.0%) had hemoglobin levels < 11
gm/dL (all aged < 15 years), and only one participant’s (0.2%)
hemoglobin was less than 8 gm/dL. A total of 469 participants
(82.7%) were followed through the end of the study period,
with most of them prematurely withdrawn because of moving
out of the study area (Figure 2). Three participants died: a 60-
year-old male because of chronic liver failure, a 48-year-old
female because of pulmonary tuberculosis, and a 6-year-old
male because of a diarrheal illness.
Longitudinal measures of transmission.Over the 2 years
of follow-up, which roughly corresponded to the fourth and
fifth years following the initiation of IRS, a total of 15,780 fe-
male Anopheles mosquitoes were collected, resulting in a
daily HBR of 2.07. Sporozoites were detected in only nine
mosquitoes, and the overall annual EIR was 0.43. Continuing
the trend that started after IRS was initiated, 98% of mos-
quitoes collectedwere from theAn. gambiae s.l. complex, and
almost 99% of these were identified as An. arabiensis by PCR
(Table 2). Longitudinal measures of transmission are pre-
sented in Figure 3. Only one annual peak in vector density was
observed between May and June. This peak occurred in the
last year of follow-up despite the fact that IRS had been ad-
ministered 3 months earlier (March–April 2019, just before the
annual peak), whereas prior rounds of pirimiphos-methyl were
administered in June–July.
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Longitudinal measures of disease. Only 38 episodes of
symptomatic malaria were diagnosed in more than 955 total
person years of follow-up, giving an overall incidence of 0.040
episodes/person/year (Table 3). Plasmodium falciparum was
detected in 37 cases, and one case was due to Plasmodium
malariae. No participants were diagnosed with symptomatic
malaria more than once, and no episodes of severe malaria
were observed, although two episodes of malaria with danger
signs were documented in children younger than 5 years
(vomiting and lethargy in a 1-year-old child and lethargy and
inability to sit upright in a 3-year-old child). When stratified by
age-group, the incidence of malaria was similar in children
younger than 5 years (0.048 episodes/person/year) and chil-
dren aged 5–15 years (0.050 episodes/person/year), but lower
among those older than 15 years (0.020 episodes/person/
year). Restricting analyses to children aged 0.5–10 years, the
FIGURE 1. Temporal changes in entomological measures of transmission, incidence of malaria, and prevalence of parasitemia from the first
cohort study (October 2011–September 2017). (A) Monthly trends of daily human biting rates, annual entomological inoculation rates, and rainfall.
(B) Monthly trends of symptomatic malaria, microscopic parasitemia, and combined microscopic and submicroscopic parasitemia. (Blue bars
signify rounds of mass long-lasting insecticidal net distribution, pink bars rounds of indoor residual spraying [IRS] with bendiocarb, and yellow bars
rounds of IRS with pirimiphos-methyl.)
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incidence of malaria was 0.054 episodes/person/year com-
pared with 2.96 episodes/person/year before the imple-
mentation of IRS from our prior cohort study. Longitudinal
trends inmalaria cases stratified by age-groups are presented
in Figure 4A. A few cases were diagnosed early in the study,
and, then, two peaks were seen approximately 1 year apart,
roughly correlating with the peaks in vector density, given a 1-
to 2-month lag. The prevalence of anemia (routine hemoglo-
bin < 11 gm/dL) was highest in children younger than 5 years
(8.8%), lower in those aged 5–15 years (2.0%), and lowest in
those older than 15 years (0.7%). The prevalence of moderate
to severe anemia (routine hemoglobin < 8 gm/dL) was only
0.3% in children younger than 5 years (8.8%), 0.7% in those
aged 5–15 years, and 0.1% in those older than 15 years.
Longitudinal measures of infection. Routine visits were
conducted every 4weeks, resulting in 12,696 total evaluations
over the study period. The overall prevalence of microscopic
parasitemia was 1.9%, with the highest prevalence in children
aged5–15 years (3.3%), lower in children younger than5 years
(1.2%), and lowest in those older than 15 years (0.8%)
(Table 3). Longitudinal trends in the prevalence of micro-
scopic parasitemia stratified by age-groups are presented in
Figure 4B (see https://clinepidb.org/ce/app/workspace/
strategies/import/7eeab4ea9951b3cd for a plot in which
you can stratify by other variables). Overall, there was a
gradual decrease in the prevalence of microscopic para-
sitemia during the first 18 months followed by increases
during the last 6 months of follow-up. The overall combined
prevalence of microscopic and submicroscopic parasitemia
was 10.4%, which was more than five times higher than the
prevalence of microscopic parasitemia alone. The ratio of
submicroscopic to microscopic parasitemia increased with
increasing age, which is expected, given the association
between age and acquired antimalarial immunity (Table 3).
Similar to microscopic parasitemia, the combined preva-
lence of microscopic and submicroscopic parasitemia was
highest among children aged 5–15 years (14.0%); however,
unlike for microscopic parasitemia, prevalence was also
relatively high among those older than 15 years (10.8%) and
lowest in children younger than 5 years (1.9%). Restricting
analyses to children aged 0.5–10 years, the prevalence of
TABLE 1
Characteristics of households and cohort participants at enrollment
Characteristic Finding
Households (n = 80)
Number of household members,
median (range)
6 (3–8)
Type of housing construction, n (%) Traditional 58 (72.5)
Modern 22 (27.5)
Number of rooms used for sleeping,
median (range)
2 (1–3)
Number of sleeping spaces,
median (range)
3 (1–7)
LLINs per household, mean (SD) 3.5 (1.6)
LLINs per person per household,
mean (SD)
0.61 (0.29)
Households with at least one LLIN,
n (%)
78 (97.5)
Households with one LLIN per two
persons, n (%)
56 (70.0)
Cohort participants (n = 531)
Female gender, n (%) 278 (52.4)
Age categories (years), n (%) < 5 177 (33.3)
5–15 193 (36.4)
> 15 161 (30.3)
Microscopic parasitemia stratified by
age categories (years), n (%)
< 5 10 (5.7)
5–15 16 (8.3)
> 15 2 (1.2)
Microscopic or submicroscopic
parasitemia stratified by age
categories (years), n (%)
< 5 16 (9.0)
5–15 45 (23.3)
> 15 31 (19.3)
Hemoglobin level stratified by age
categories (years), mean (SD)
< 5 12.7 (1.3)
5–15 14.2 (1.3)
> 15 15.9 (1.4)
LLINs = long-lasting insecticidal nets.FIGURE 2. Flow diagram of the current cohort study (PRISM2; Oc-
tober 2017–October 2019).
TABLE 2
Longitudinal entomological metrics using CDC light traps
Metric








Total number of female
Anopheles collected
15,780 15,462 38 280
Total nights of collections 7,635
Daily human biting rate* 2.07 2.03 0.005 0.037
Number positive for sporozoites 9 9 0 0
Sporozoite rate, % 0.0006 0.0006 0 0
Annual entomological
inoculation rate†
0.43 0.43 0 0
Number tested by PCR for
species
N/A 1,325 N/A N/A
An. arabiensis, n (%) 1,310
(98.9)
An. gambiae s.s., n (%) 15 (1.1)
An. arabiensis = Anopheles arabiensis; An. gambiae = Anopheles gambiae.
* Number of female Anopheles per room per night of collection using CDC light traps.
†Number of infective bites per person per year.
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combined microscopic and submicroscopic parasitemia
was 6.8% compared with 67.5% before the implementation
of IRS from our prior cohort study. Longitudinal trends in the
prevalence of combined microscopic and submicroscopic
parasitemia stratified by age-groups are presented in
Figure 4C. Trends were similar to those for microscopic
parasitemia, with a gradual decrease in the prevalence of
combined microscopic and submicroscopic parasitemia
during the first 18 months followed by increases during the
last 6 months of follow-up. Interestingly, between May and
June 2019, there were no cases of malaria or parasitemia
detected by microscopy or qPCR in children younger than 5
years. This 4-month period was followed by an increase in
the prevalence of parasitemia, with six cases diagnosed in
this age-group.
DISCUSSION
We describe the epidemiology of malaria following two
rounds of universal LLIN distribution and sustained IRS in
Tororo, Uganda, a district with historically intense malaria
transmission. We studied dynamic cohorts in which all par-
ticipants received LLINs and prompt treatment of malaria
episodes with an ACT. Comparing the period 4–5 years after
IRS initiationwith the 3-year period before implementation, we
observed 1) a reduction in transmission of more than 500-fold
(annual EIR 0.43 versus 238), 2) a reduction in disease of more
than 50-fold (malaria incidence among children aged 0.5–10
years0.054 versus2.96), and3) a reduction in infectionof∼10-
fold (prevalence of combined microscopic and submicroscopic
parasitemia among children aged 0.5–10 years 6.8% versus
67.5%). However, despite the reduction in malaria burden to
very low transmission levels, a significant proportion of the
population remained parasitemic, providing a potential res-
ervoir for malaria transmission.
The observed decline in transmission intensity was due to a
combination of marked reductions in both vector density and
the sporozoite rate. When mosquitoes absorb lethal doses of
insecticides, their life span is reduced, resulting in declines in
vector density and vectoral capacity.17 Although there was
some evidence of modest declines in transmission intensity
following the first round of universal LLIN distribution, marked
declines were not seen until after IRS was implemented. We
cannot rule out a role for changes in climate in the decreasing
malaria burden,18 butwedidnot observeappreciable changes
in monthly rainfall over the observation period. Indeed, one
FIGURE 3. Temporal changes in entomological measures of transmission in the current cohort study (October 2017–October 2019). Monthly
trends of daily human biting rates, annual entomological inoculation rates, and rainfall in the current study. (Yellow bars signify rounds of indoor
residual spraying with pirimiphos-methyl.)
TABLE 3
Longitudinal clinical metrics among cohort participants
Measure
Age-group (years)
All < 5 5–15 > 15
Person years of follow-up 954.5 250.4 400.0 304.4
Incident episodes of malaria 38 12 20 6
Incidence of malaria per person years 0.040 0.048 0.050 0.020
Prevalence of microscopic parasitemia* 244/12,696 (1.9%) 40/3,352 (1.2%) 173/5,307 (3.3%) 31/4,037 (0.8%)
Geometric mean parasite density/μL
(95% CI)
200 (157–256) 540 (262–1,110) 165 (127–215) 165 (77–356)
Prevalence of microscopic or
submicroscopic parasitemia*
1,314/12,695 (10.4%) 134/3,352 (4.0%) 743/5,306 (14.0%) 437/4,037 (10.8%)
Geometric mean parasite density/μL
(95% CI)
3 (2–3) 6 (3–13) 5 (4–6) 1 (1–1)
Prevalence of microscopic
gametocytemia*
50/12,696 (0.4%) 15/3,352 (0.5%) 30/5,307 (0.6%) 5/4,037 (0.1%)
Prevalence of anemia (Hb < 11 gm/dL)† 146/4,334 (3.4%) 101/1,147 (8.8%) 36/1813 (2.0%) 9/1,374 (0.7%)
*Measured at the time of routine visits (enrollment and every 4 weeks during follow-up).
†Measured at the time of routine visits (enrollment and every 12 weeks during follow-up).
6 NANKABIRWA AND OTHERS
interesting observation after the implementation of IRS was
the loss of a peak in transmission intensity following the
October–November rainy season, resulting in only a single
annual peak after the longer rains inMarch–May. Following the
implementation of IRS, we also observed a dramatic shift in
the predominate vector species from An. gambiae s.s. to An.
arabiensis. This shift has also been reported previously from a
studyof human landing catchesperformed in the same region,
FIGURE 4. Temporal changes in the incidence of malaria and prevalence of parasitemia from the current cohort study (October 2017–October
2019). (A) Monthly episodes of symptomaticmalaria stratified by age-group. (B) Monthly trends ofmicroscopic parasitemia stratified by age-group.
An interactiveplot is availableat https://clinepidb.org/ce/app/workspace/strategies/import/7eeab4ea9951b3cd. (C)Monthly trendsofmicroscopic
or submicroscopic parasitemia stratified by age-group. (Yellow bars signify rounds of indoor residual spraying with pirimiphos-methyl.)
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which also documented an increase in the proportion of
mosquitoes collected outdoors versus indoors following the
implementation of IRS.19
Before the implementation of IRS, the incidence of malaria
among children at our study site peaked at more than four
episodes per year in children younger than 3 years, with a
sharp decline to just more than one episode per year in chil-
dren aged 3–10 years, as previously described.4 However,
despite the high burden of malaria before IRS, less than 0.2%
of episodes met the criteria for severe malaria, and there were
no deaths due to malaria, which we attributed to access to
prompt and effective treatment in our cohorts. Following 5
years of sustained IRS, there was a dramatic decline in the
incidence of malaria, with a modest shift in the burden toward
older children. In high endemic settings, repeated exposure to
malaria parasites leads to the development of naturally ac-
quired immunity, which provides protection against clinical
disease in older age-groups.20 However, as transmission
declines, it is expected that acquisition of immunity is lost or
delayed, consistent with a shift of the burden of malaria to
older children, as we observed following IRS.21 Although we
only observed 38 cases of malaria in the 4–5 years after IRS
was implemented, it is comforting that there were no cases of
severe malaria or deaths due to malaria. Thus, with prompt
access to treatment, outcomes of malaria episodes remained
excellent despite reduced parasite exposure and presumed
delays in the acquisition of immunity. In addition, the preva-
lence of anemia was very low after sustained IRS, with mod-
erate to severe anemia in only 0.3% in children younger than 5
years compared with findings from national MIS, in which the
prevalence of moderate to severe anemia in this same age-
group was 10% in 2009 and 5% in 2014.2,3 Indeed, we have
previously reported significant increases in mean hemoglobin
levels among children in our cohort studies following the
implementation of IRS.22
As observed with measures of transmission and disease,
therewas amarked reduction in the prevalence of parasitemia
following sustained IRS. After 5 years of IRS, the overall par-
asite prevalence by microscopy had fallen to < 2%. However,
when using a highly sensitive qPCR assay, most of the in-
fections were submicroscopic such that the prevalence of
combined microscopic and submicroscopic parasitemia was
more than 10%. In addition, the proportion of infections that
were submicroscopic increased with age such that older
children and adults were the primary foci of infection. The
persistence of these largely asymptomatic, low-level infec-
tions in older children and adults likely has significant impli-
cations formalaria elimination inUganda and other historically
high-burden African countries. Achieving malaria elimination
requires removal of the human reservoir of infection, including
asymptomatic and submicroscopic infections, which are
known to be transmissible to mosquitoes.23,24 These findings
suggest that a combination of case management with ACTs,
universal LLIN distribution, and IRS in a limited geographical
setting may not be sufficient for the elimination of malaria in
previously high transmission settings where An. arabiensis is
present, and rather that combining vector control interven-
tions with other interventions that target the human reservoir,
such as regular chemoprevention, done at a large spatial scale
may be needed to achieve elimination.25 The persistence of
the human reservoir after 5 years of sustained IRS also raises
concerns about IRS exit strategies. Indeed, withdrawal of IRS
in a historically high-burden area of Northern Uganda was
associated with a rapid resurgence of malaria burden to pre-
IRS levels.26
This study had several limitations. First, the observational
study design and lack of a contemporary control group limit
our ability to make causal inferences about the impact of IRS
on our measures of malaria transmission, disease, and in-
fection. However, given continued implementation of LLINs
and case management with ACTs, the magnitude of the
changes observed, and their temporal relationship to IRS, it is
highly likely that IRSwas themajor contributor to the observed
declines. Second, different methods were used to detect
submicroscopic parasitemia in our two cohort studies. Be-
cause the qPCR assay used in the second cohort study was
more sensitive than the LAMPassay used in the first study, we
likely underestimated the decline in the prevalence of com-
bined microscopic and submicroscopic parasitemia over
time. Third, entomologicalmeasures of transmission intensity,
including the HBR and EIR, were estimated using CDC light
trapsandnot standardizedcollectionmethods suchashuman
landing catches. Therefore, caution should be taken when
interpreting these estimates. Finally, our study cannot be
considered representative of rural African settings, as partic-
ipants in our cohort studies received higher quality medical
care in a more timely manner than is typically available.
However, over the course of our two cohort studies, the pro-
cedures we used to manage patients did not change.
We have demonstrated that, in a highly endemic area of
Uganda, a combination of available malaria control interven-
tions including case management with ACTs, universal LLIN
distribution, and sustained IRS was associated with a dra-
matic reduction in the burden of malaria. The vision of the
UgandaNationalMalariaControl Program is to haveamalaria-
free Uganda by accelerating the nationwide scale-up of evi-
dence-based malaria reduction interventions by the govern-
ment, its development partners, the private sector, and all
stakeholders.27 Uganda has already implemented a national
policy of universal access to ACTs for case management and
LLIN distribution repeated every 3–4 years. However, IRS is
currently only being implemented in 14 of 135 districts be-
cause of limited resources. For Uganda to accelerate gains
and achieve the success seen in Tororo district, additional
resources to scale-up IRS to other high-burden areaswill be of
great value. In addition, even in areas where IRS has been
implemented, there is a need to sustain this intervention, given
the reservoir of largely asymptomatic infections that persisted
after 5 years of IRS in Tororo and the risk of reintroduction from
neighboring areas that have not achieved the same level of
control.
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